MMPs are regulatory enzymes in pathways of inflammatory disorders, tissue injury, malignancies and remodelling of the lung

Müller-Quernheim J.

Source: Eur Respir J 2011; 37: 12-14
Journal Issue: July
Disease area: Airway diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Müller-Quernheim J.. MMPs are regulatory enzymes in pathways of inflammatory disorders, tissue injury, malignancies and remodelling of the lung. Eur Respir J 2011; 37: 12-14

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The role of pathological angiogenesis in the pathogenesis of the chronic inflammatory lung diseases
Source: Annual Congress 2005 - Update on the role of angiogenesis in the pathogenesis and treatment of lung diseases
Year: 2005

Polymorphisms of genes involved in extracellular matrix remodeling, xenobiotic metabolism, antioxidant pathways and chronic lung disease in children
Source: Annual Congress 2012 - COPD inflammation and genes
Year: 2012

A role of matrix metalloproteinases and their inhibitors in the pathogenesis of fibrosis and angiogenesis in lung precancer processes
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010

Tezepelumab decreases matrix remodelling and inflammatory pathways in patients with asthma
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Asthma
Year: 2019




Matrix metalloproteinases in acute lung injury: mediators of injury and drivers of repair
Source: Eur Respir J 2011; 38: 959-970
Year: 2011



Are circulating progenitors involved in the repair of lung tissue?
Source: Annual Congress 2007 - Circulating progenitors as new actors in health and disease: angiogenesis and tissue repair
Year: 2007


Investigation of the citrullination pathway in the pathogenesis of fibrotic lung disorders
Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities
Year: 2012


Nintedanib inhibits pro-fibrotic mediators from T cells with relevance to connective tissue disease-associated interstitial lung disease
Source: International Congress 2017 – Lung fibrosis: basic science
Year: 2017

The clinical spectrum and pathogenesis of pulmonary manifestations in connective tissue diseases
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=1
Year: 2005

Endothelin-1 induced connective tissue growth factor expression in human lung fibroblasts by ETAR-dependent JNK/AP-1 pathway
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013

Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction
Source: Eur Respir J 2008; 31: 1334-1356
Year: 2008



The role of chronic inflammation in mouse lung tumourigenesis
Source: Annual Congress 2005 - Pathophysiology of lung cancer progression: impact in diagnosis and early detection
Year: 2005

Matrikines in lung inflammation
Source: ERS Lung Science Conference 2018
Year: 2018

The role of mitochondrial DAMPs in driving lung inflammation and injury
Source: International Congress 2016 – Dysfunctional mitochondria in respiratory disease
Year: 2016


A therapeutic role for matrix metalloproteinase inhibitors in lung diseases?
Source: Eur Respir J 2011; 38: 1200-1214
Year: 2011



Down regulation of type V collagen triggers angiogenesis and immune response disfunction in lung cancer microenvironment
Source: Annual Congress 2010 - New insights in the pathology of lung cancer
Year: 2010


Immunological mechanisms in pleural disease
Source: Eur Respir J 2003; 21: 539-544
Year: 2003



Immunological mechanisms in pleural disease
Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=50
Year: 2002

B cell activating factor belonging to the TNF family might be a useful biomarker in interstitial lung diseases associated with connective tissue diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013


Hsp90 binding inhibitors improve survival in a murine model of sepsis induced acute lung injury
Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS)
Year: 2006